Hajebi, Mahsa
Farzi, Yosef
Fe’li, Shadi Naderian
Sharifi, Farshad
Rezaei, Nazila
Mirzad, Mina
Ebrahimpur, Mahbube
Payab, Moloud
Article History
Received: 26 September 2025
Accepted: 30 January 2026
First Online: 18 March 2026
Declarations
:
: The authors declare no competing interests.
: Ethical approval for the study was granted following the latest Declaration of Helsinki by the research Ethics Committees of the Endocrine and Metabolism Research Institute, Tehran University of Iran (IR.TUMS.EMRI.REC.1403.053). All participants were fully informed about the study’s objectives and procedures. The entire study process was kept confidential, with access to the survey database restricted to the database manager, and the primary investigator. Each participant provided written informed consent, and in the case of illiterate and cognitively impaired participants, a legal guardian signed the informed consent form on their behalf. Involvement in this research was optional and had no effect on the treatment procedures of participants. Individuals had the option to exit the survey whenever they chose.